Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$1.64B |
| 2 |
Microsoft
MSFT
|
+$1.44B |
| 3 |
NVIDIA
NVDA
|
+$1.17B |
| 4 |
Gilead Sciences
GILD
|
+$1.08B |
| 5 |
Eli Lilly
LLY
|
+$996M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$1.38B |
| 2 |
Apple
AAPL
|
+$1.21B |
| 3 |
United Parcel Service
UPS
|
+$1.06B |
| 4 |
T-Mobile US
TMUS
|
+$908M |
| 5 |
McDonald's
MCD
|
+$883M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.86% |
| 2 | Financials | 15.98% |
| 3 | Healthcare | 15.38% |
| 4 | Consumer Discretionary | 9.68% |
| 5 | Industrials | 9.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1451
Corcept Therapeutics
CORT
$12.4B
| $2.46M | ﹤0.01% |
33,534
-1,976
| -6% | -$143K |
|
1452
BridgeBio Pharma
BBIO
$15.7B
| $2.45M | ﹤0.01% |
56,669
-3,342
| -6% | -$122K |
|
|
RDUS
1453
DELISTED
Radius Recycling
RDUS
| $2.44M | ﹤0.01% |
82,302
-11,371
| -12% | -$334K |
|
1454
TransAlta
TAC
$3.89B
| $2.42M | ﹤0.01% |
225,231
| – | – |
|
1455
Colony Bankcorp
CBAN
$465M
| $2.4M | ﹤0.01% |
145,790
| – | – |
|
1456
Healthpeak Properties
DOC
$14.9B
| $2.38M | ﹤0.01% |
135,869
+8,713
| +7% | +$155K |
|
1457
Millicom
TIGO
$15.8B
| $2.36M | ﹤0.01% |
+62,900
| New | +$2.15M |
|
1458
Praxis Precision Medicines
PRAX
$8.57B
| $2.35M | ﹤0.01% |
55,881
+5,105
| +10% | +$194K |
|
1459
AptarGroup
ATR
$8.69B
| $2.34M | ﹤0.01% |
14,931
-106
| -0.7% | -$16K |
|
|
BAND
1460
Bandwidth Inc
BAND
$1.41B
| $2.34M | ﹤0.01% |
146,859
+55,824
| +61% | +$759K |
|
1461
Allstate
ALL
$67.5B
| $2.33M | ﹤0.01% |
11,593
-40,354
| -78% | -$8.05M |
|
1462
BorgWarner
BWA
$13B
| $2.33M | ﹤0.01% |
69,706
+31,490
| +82% | +$965K |
|
1463
State Street Technology Select Sector SPDR ETF
XLK
$117B
| $2.32M | ﹤0.01% |
18,340
-21,926
| -54% | -$2.43M |
|
1464
Evergy
EVRG
$19.2B
| $2.32M | ﹤0.01% |
33,648
+16,196
| +93% | +$1.09M |
|
|
PARA
1465
DELISTED
Paramount Global Class B
PARA
| $2.29M | ﹤0.01% |
177,204
| – | – |
|
1466
Camden National
CAC
$1.01B
| $2.29M | ﹤0.01% |
56,314
+2,930
| +5% | +$115K |
|
1467
SLM Corp
SLM
$5.13B
| $2.28M | ﹤0.01% |
69,498
+16,121
| +30% | +$493K |
|
1468
Zymeworks
ZYME
$1.61B
| $2.27M | ﹤0.01% |
180,690
-1,556
| -0.9% | -$18.5K |
|
1469
Oric Pharmaceuticals
ORIC
$1.11B
| $2.27M | ﹤0.01% |
223,302
+45,085
| +25% | +$303K |
|
1470
Revvity
RVTY
$12.9B
| $2.24M | ﹤0.01% |
23,200
+663
| +3% | +$62.5K |
|
1471
General Mills
GIS
$19.2B
| $2.24M | ﹤0.01% |
43,163
+8,773
| +26% | +$484K |
|
1472
Madrigal Pharmaceuticals
MDGL
$11.1B
| $2.23M | ﹤0.01% |
7,379
-249
| -3% | -$74.2K |
|
1473
Super Micro Computer
SMCI
$18.5B
| $2.23M | ﹤0.01% |
45,529
+1,281
| +3% | +$49.4K |
|
1474
Franklin Electric
FELE
$4.72B
| $2.21M | ﹤0.01% |
24,630
-11,624
| -32% | -$1.02M |
|
1475
iShares MSCI UAE ETF
UAE
$312M
| $2.2M | ﹤0.01% |
117,742
-9,225
| -7% | -$164K |
|
Similar funds
Wellington Management Group's Q2 2025 Portfolio in Review
As of Q2 2025, Wellington Management Group held 2,080 positions worth $551B, up 6% from $520B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Wellington Management Group's Q2 2025 filing shows 139 new, 795 increased, 834 reduced and 147 closed positions. Its largest new stake was Amrize Ltd: 7,812,891 shares worth $388M. The largest sale was Procter & Gamble, an estimated $1.38B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
- Wellington Management Group's largest Q2 2025 buy was Amrize Ltd: 7,812,891 shares worth $388M.
- Wellington Management Group added most to Alphabet (Google) Class A in Q2 2025, an estimated $1.64B increase.
- Wellington Management Group's biggest Q2 2025 reduction was Procter & Gamble, cutting an estimated $1.38B.
- Wellington Management Group fully exited iShares Russell 1000 Growth ETF in Q2 2025, selling an estimated $464M.
- Wellington Management Group's ten largest holdings make up 25% of its $551B portfolio in Q2 2025.
- Wellington Management Group opened 139 new positions and closed 147 in Q2 2025.
- Wellington Management Group's portfolio value rose 6% quarter-over-quarter to $551B.
Based on Wellington Management Group's 13F filing for Q2 2025, filed 14 Aug 2025.